Pakistan's Vaccine Supply Disruption
Analysis based on 6 articles · First reported Feb 07, 2026 · Last updated Feb 09, 2026
The disruption of vaccine supplies from India to Pakistan is expected to significantly increase Pakistan's annual vaccine import bill, potentially reaching $1.2 billion by 2031, straining its already fragile economy. This situation highlights the vulnerability of public health systems to geopolitical tensions and could lead to increased investment in domestic pharmaceutical production within Pakistan.
Pakistan's Health Minister, Mustafa Kamal, announced that the disruption of cost-effective vaccine supplies from India, following military clashes in May 2025, has severely strained Pakistan's economy and public health system. Historically, Pakistan relied on vaccines procured through GAVI, largely sourced from India. With international support for vaccine procurement expected to end by 2031, Pakistan faces a projected annual import bill of $1.2 billion if it does not develop local vaccine production capabilities. The government has begun preparatory work to achieve self-sufficiency in vaccine production. The supply halt was a consequence of India's 2025 India–Pakistan conflict, launched in retaliation for the India — Pahalgam attack.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard